Studies with Magnesium Sulfate in 5% Dextrose Injection have not been performed to evaluate carcinogenic potential, mutagenic potential or effects on fertility.
Magnesium Sulfate in 5% Dextrose Injection, USP is supplied in a single-dose, single port bag with an aluminum overwrap. The infusion bags and ports are not made with natural rubber latex.
|NDC Number||Packaging Configuration||Container Size||Total Magnesium Sulfate *||Total Magnesium Ion||Magnesium Sulfate * Concentration||Magnesium Ion Concentration||Osmolarity †|
24 bags per carton
0.01 grams/mL (1%)
8.1 mEq/100 mL
WARNING: DO NOT USE FLEXIBLE CONTAINER IN SERIES CONNECTIONS.
Store at 20°C to 25°C (68°F to 77°F). [See USP Controlled Room Temperature.]
PROTECT FROM FREEZING
Magnesium Sulfate in 5% Dextrose Injection is typically administered to pregnancy women in emergent situations. When feasible, advise the patient and family of the following:
Fetal-Neonatal Toxicity Reported With Prolonged Use
Continuous administration of Magnesium Sulfate in 5% Dextrose Injection in pregnant women beyond 5 to 7 days can lead to hypocalcemia and bone abnormalities in the developing fetus, including skeletal demineralization and osteopenia. In addition, cases of neonatal fracture have been reported [see Warnings and Precautions (5.1)].
Risk of Magnesium Toxicity
Pregnant women receiving Magnesium Sulfate in 5% Dextrose Injection are at risk for magnesium toxicity, including facial edema, diminished strength of deep tendon reflexes, and respiratory depression [see Warnings and Precautions (5.2)].
WG Critical Care, LLC
Paramus, NJ 07652
Made in Switzerland
NDC 44567-410-24 100 mL
in 5% Dextrose Injection, USP
(0.081 mEq Mg++/mL) 10 mg/mL
1 g Total
| MAGNESIUM SULFATE |
magnesium sulfate injection
|Labeler — WG Critical Care, LLC (829274633)|
|Registrant — HQ Specialty Pharma Corporation (962364332)|
|InfoRLife SA||481732753||MANUFACTURE (44567-410)|
Revised: 08/2019 WG Critical Care, LLC
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.